ROYAL BANK OF CANADA - AMAG PHARMACEUTICALS INC ownership

AMAG PHARMACEUTICALS INC's ticker is and the CUSIP is 00163UAA4. A total of 13 filers reported holding AMAG PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of AMAG PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2018$4,0000.0%4,0000.0%0.00%
Q3 2018$4,0000.0%4,0000.0%0.00%
Q2 2018$4,0000.0%4,0000.0%0.00%
Q1 2018$4,0000.0%4,0000.0%0.00%
Q4 2017$4,0000.0%4,0000.0%0.00%
Q3 2017$4,0000.0%4,0000.0%0.00%
Q2 2017$4,0004,0000.00%
Other shareholders
AMAG PHARMACEUTICALS INC shareholders Q2 2017
NameSharesValueWeighting ↓
Birch Grove Capital LP 7,424,000$7,748,0004.66%
Bruce & Co., Inc. 5,500,000$5,500,0001.26%
IRON Financial LLC 1,025,000$1,066,0000.94%
TENOR CAPITAL MANAGEMENT Co., L.P. 9,291,000$9,812,0000.90%
Sonora Investment Management, LLC 1,430,000$1,495,566,0000.28%
CSS LLC/IL 3,305,000$3,445,0000.17%
FMR LLC 5,100,000$5,247,0000.00%
Allianz Asset Management GmbH 700,000$728,0000.00%
JPMORGAN CHASE & CO 4,365,000$4,605,0000.00%
North Star Investment Management Corp. 1,000$1,0000.00%
View complete list of AMAG PHARMACEUTICALS INC shareholders